Effects of hepatitis A vaccination on atherogenesis in a murine model

Journal of Viral Hepatitis

Volumn 10, Issue 6, 2003, Pages 433-436

  Burnett, M S ^a   Zhu, J ^a   Miller, J M ^a   Epstein, S E ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

Antibody; Atherosclerosis; Cholesterol; Hepatitis A; Vaccine

Indexed keywords

ADJUVANT; CHOLESTEROL; HEPATITIS A ANTIBODY; HEPATITIS A VACCINE; IMMUNOGLOBULIN G ANTIBODY; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; HEART PROTECTION; HEPATITIS A; HEPATITIS A VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEROLOGY; VACCINATION;

ANIMALS; ARTERIOSCLEROSIS; CHOLESTEROL; DISEASE MODELS, ANIMAL; HEPATITIS A ANTIBODIES; HEPATITIS A VACCINES; MICE; MICE, INBRED C57BL; SINUS OF VALSALVA;

EID: 0242298693     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.2003.00451.x     Document Type: Article

References (12)

1. Adam E, Probtsfield JL, Burek J et al High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis. Lancet 1987; 2: 291-293.
2. Nieto FJ, Adam E, Sorlie P et al. Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. Circulation 1996; 94: 922-927.
3. Zhu J, Quyyumi AA, Norman JE, Csako G, Epstein SE. Cytomegalovirus in the pathogenesis of atherosclerosis: the role of inflammation, as reflected by elevated C-reactive protein levels. J Am Coll Cardiol 1999; 34: 1738-1743.
4. Saikku P, Leinonen M, Mattila K et al. Serological evidence of an association of a novel chlamydia TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988; 2: 983-986.
5. Thom DM, Grayston JT, Siscovitch DS, Wang SP, Weiss NS, Daling JR. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA 1992; 268: 68-72.
6. Anderson J, Carlquist JF, Muhlestein JB et al. Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction. J Am Coll Cardiol 1998; 32: 35-41.
7. Mendall MA, Goggin PM, Molineaux N et al. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 1994; 71: 437-439.
8. Rathbone B, Martin D, Stephens J, Thompson JR, Samani NJ. Helicobacter pylori infection seropositivity in subjects with acute myocardial infarction. Heart 1996; 76: 308-311.
9. Sorlie PD, Adam E, Melnick SL et al. Cytomegalovirus/herpesvirus and carotid atherosclerosis: the ARIC study. J Med Virol 1994; 42: 33-37.
10. Zhu J, Quyyumi AA, Norman JE et al. Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. Am J Cardiol 2000; 85: 140-146.
11. Zhu J, Quyyumi AA, Norman JE, Costello R, Csako G, Epstein SE. The possible role of hepatitis A virus in the pathogenesis of atherosclerosis. J Infect Dis 2000; 182: 1583-1587.
12. Paigen B, Holmes PA, Mitchell D, Albee D. Comparison of atherosclerotic lesions and HDL-lipid levels in male, female, and testosterone-treated female mice from strains C57BL/6, BALB/c, and C3H. Atherosclerosis 1987; 64: 215-221.